| Patient | Abraham Lincoln |
|---|---|
| Date of birth | 1809-02-12 |
| Identifiers | MRN HR-NI001-SYN-TD; SSN (made up) 000-01-6683 |
| Document date | 1841-10-27 |
| Author | Elena Marquez, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Adult preventive visit; no new complaints. [S]
Mr. Lincoln returns for an adult preventive visit, four weeks after his twelve-week depression review. He completed the health risk assessment before the visit. The poison ivy rash cleared during the prednisone taper, which he finished four days ago, with no rebound. He slept more lightly on the first three nights of the 60 mg dose but had no mood change, racing thoughts, or irritability, and the nurse telephone check four days into the course found the rash improving and his sleep back to normal. His mood has stayed good, his PHQ-9 is 3 today, and he has had no suicidal thoughts. He continues sertraline 50 mg daily and misses about one dose every two weeks. He walks most evenings and is working full days. [S]
| Element | Detail |
|---|---|
| Visit | Adult preventive visit, established patient |
| Recent illness | Poison ivy dermatitis, cleared; prednisone taper finished four days ago |
| Depression | In remission for about a month on sertraline 50 mg; PHQ-9 3 |
| Safety events | No emergency visits, hospital stays, or injuries |
| Medicines | Sertraline 50 mg daily; no over-the-counter medicines or supplements |
| Functional status | Independent in all activities; working full days |
Health risk assessment. Completed by the patient before the visit and reviewed during the visit. [S]
| Domain | Finding |
|---|---|
| Self-rated health | Good, and better than in the summer |
| Psychosocial | Close friend and law colleagues; values correspondence and storytelling; work stress manageable; no loneliness |
| Behavioral | No current tobacco or nicotine use; no alcohol; no nonprescribed drugs; walks most evenings; regular meals; sleeps about seven hours |
| Activities of daily living | Independent |
| Instrumental activities of daily living | Manages his own medicines, money, and work schedule |
| Home and personal safety | Smoke detectors working; wears a seat belt; access to lethal means reviewed again and unchanged since the intake review |
| Sexual health | Asked privately; no concerns |
| Vision, hearing, and dental | No vision or hearing concerns; sees a dentist yearly |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Weight stable; no fever, fatigue, or night sweats |
| Eyes | Negative | No change in vision |
| Ears, nose, mouth, and throat | Negative | No hearing change, sore throat, or dental pain |
| Cardiovascular | Negative | No chest pain, palpitations, or ankle swelling |
| Respiratory | Negative | No cough or breathlessness |
| Gastrointestinal | Negative | Regular bowel habit; no heartburn, bleeding, or abdominal pain |
| Genitourinary | Negative | No urinary symptoms; no sexual side effects |
| Musculoskeletal | Negative | No joint pain or injury |
| Integumentary | Negative | Rash cleared; no new or changing skin lesions |
| Neurological | Negative | No headache, numbness, or weakness |
| Psychiatric | Negative | Mood good; sleeping about seven hours; PHQ-9 3 with item 9 scored 0; GAD-7 2; no suicidal thoughts |
| Endocrine | Negative | No heat or cold intolerance, polyuria, or polydipsia |
12 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Sertraline 50 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 1841-06-30 | active | S |
| Prednisone 20 mg oral tablet, tapering course: three tablets each morning for 5 days, two for 5 days, then one for 5 days | Each morning with breakfast: 60 mg for 5 days, 40 mg for 5 days, then 20 mg for 5 days | Oral route | 1841-10-09 to 1841-10-23 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1841-10-27 | Body height | 193 | cm | S |
| 1841-10-27 | Body weight | 83.4 | kg | S |
| 1841-10-27 | Body mass index (BMI) [Ratio] | 22.4 | kg/m2 | S |
| 1841-10-27 | Systolic blood pressure | 116 | mm[Hg] | S |
| 1841-10-27 | Diastolic blood pressure | 70 | mm[Hg] | S |
| 1841-10-27 | Heart rate | 64 | /min | S |
| 1841-10-27 | Respiratory rate | 14 | /min | S |
| 1841-10-27 | Body temperature | 36.6 | Cel | S |
| 1841-10-27 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1841-10-27 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 3 | {score} | S | ||
| 1841-10-27 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 2 | {score} | S | ||
| 1841-10-27 | Total score [AUDIT-C] | 0 | {score} | S |
Vital signs recorded on 1841-10-27; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| Constitutional | Alert and well-appearing; BMI 22.4 |
| Eyes | Pupils equal and reactive; conjunctivae clear |
| Ears, nose, and throat | Tympanic membranes normal; oropharynx normal; teeth in good repair |
| Neck | No thyroid enlargement or nodes |
| Cardiovascular | Regular rhythm; normal heart sounds; pedal pulses present |
| Respiratory | Clear to auscultation bilaterally |
| Abdomen | Soft and non-tender; no masses |
| Musculoskeletal | Full range of motion; normal gait |
| Skin | Faint fading pink streaks on the forearms and shins where the rash was; no blisters or infection |
| Neurological | Strength and coordination normal |
| Psychiatric | Euthymic, articulate, and humorous; affect full; no suicidal ideation; judgment and insight good |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Major depressive disorder, single episode, moderate; synthetic modern diagnosis linked to documented low mood and its retrospective interpretation | active | provisional | F32.1 | S — Synthetic active diagnosis for the teaching episode; the historical depression label remains R. |
| Allergic contact dermatitis from poison ivy, extensive, resolved with a tapering course of prednisone | resolved | confirmed | L23.7 | S — Synthetic intercurrent illness at an unscheduled visit; it does not echo a documented illness. |
Personalized prevention plan. A written copy was given to the patient. [S]
| Service | Status | Detail |
|---|---|---|
| Depression screening and monitoring | Completed today | PHQ-9 3, with item 9 scored 0; already monitored every two to four weeks in his depression care |
| Anxiety screening | Completed today | GAD-7 2 |
| Unhealthy alcohol use screening | Completed today | AUDIT-C 0 |
| Unhealthy drug use screening | Completed today | No nonprescribed drug use |
| Tobacco use | Completed today | No current tobacco or nicotine use |
| Blood pressure screening | Completed today | 116/70 mmHg; recheck at least every three to five years |
| HIV screening | Ordered | One-time antigen and antibody test, with his consent; no prior result on record |
| Hepatitis C screening | Ordered | One-time antibody test with reflex RNA, with his consent |
| Hepatitis B screening | Ordered | One-time triple panel (surface antigen, surface antibody, and core antibody) |
| Influenza vaccine | Completed today | This season's inactivated vaccine given today |
| Hepatitis B vaccine | Due | No record of a prior series; he prefers to start it when the screening panel is back |
| COVID-19 vaccine | Due | Discussed; he plans to get this season's vaccine at his pharmacy |
| Tdap | Up to date | Given about four and a half years ago; next booster in about five and a half years |
| HPV vaccine | Declined | Shared decision for adults 27 to 45; after discussion he declined |
| Live vaccines after prednisone | Not indicated | None is due. Because he took at least 20 mg of prednisone a day for 15 days, any live vaccine would wait a month after the course |
| Healthy diet and physical activity | Completed today | Walks most evenings; encouraged to keep at least 150 minutes of moderate activity a week |
| Cholesterol and statin assessment | Not indicated | Statin assessment starts at 40; no cardiovascular risk factors are recorded |
| Diabetes screening | Not indicated | For adults 35 to 70 with overweight or obesity; his BMI is 22.4 |
| Colorectal cancer screening | Not indicated | Starts at 45 |
Immunizations given today: Influenza vaccine, 1841-1842 season [S]
Guideline basis: Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026)
Follow-up: HIV, hepatitis C, and hepatitis B results will be sent when available, with a plan for the hepatitis B vaccine. Nurse telephone PHQ-9 in about four weeks. Depression review in three months. Next preventive visit in one year. [S]
Brief voluntary discussion, with his consent. He has no advance directive. He wants full treatment, including hospital care, for any illness from which he could recover. He will choose a health care agent and complete the state advance directive form given to him today, and bring it to a future visit. [S]